Evolve Medtech Partners

Venture Capital Solana Beach, United States ·Founded 2018

Overview

Evolve Medtech Partners is a medical device development company and discovery engine that collaborates with inventors, physicians, companies, and investors to efficiently advance ideas from conception through licensing, acquisition, or commercialization. Early-stage medical device companies are launched, co-located, and supported within the Evolve facility. The company provides leadership and expertise across every stage of product development, drawing on extensive experience and proven success to rapidly innovate and bring medical devices to market. Evolve and its extended partners offer deep capabilities in product development, intellectual property strategy, regulatory and quality, manufacturing, commercialization, clinical and business development. The company operates an ISO 13485:2016 and 21 CFR 820 compliant quality management system. Evolve Medtech Partners offers a comprehensive suite of services to support the development and commercialization of medical devices. Their process includes idea generation, opportunity assessment, selection and formation, and growth and liquidity stages. The company operates an ISO 13485:2016 and 21 CFR 820 compliant quality management system, ensuring adherence to industry standards. Their facility includes a wet lab, R&D workspace, and advanced development equipment, located in Solana Beach, North County San Diego, at the heart of the region’s medical device ecosystem. Evolve Medtech Partners has a diverse portfolio of medical device companies, including a breakthrough micro-catheter-based solution for treating chronic total occlusions (CTOs), a patented RF transseptal access system, a next-generation non-thermal cardiac ablation system, a pain-free, wireless, and battery-less medical device for the treatment of atrial fibrillation (Afib), single-use surgical retractor technology, endoscopic technology development structured as a build-to-buy with a strategic medical device company, over-the-wire transseptal access technology used in electrophysiology and structural heart procedures, and Vector Vascular, which is developing a catheter-based technology to assist in venous stenting procedures. These investments reflect Evolve Medtech Partners' commitment to advancing innovative medical technologies across various specialties.

Investment Focus

  • Innovative medical device concepts addressing unmet clinical needs
  • Strong intellectual property position
  • Experienced management teams
  • Clear regulatory and reimbursement pathways
  • Potential for significant market impact

Portfolio Companies

Breakthrough micro-catheter-based solution for treating chronic total occlusions (CTOs)Patented RF transseptal access systemNext-generation non-thermal cardiac ablation systemPain-free, wireless, and battery-less medical device for the treatment of atrial fibrillation (Afib)Single-use surgical retractor technologyEndoscopic technology development structured as a build-to-buy with a strategic medical device companyOver-the-wire transseptal access technology used in electrophysiology and structural heart proceduresVector Vascular

Reach Evolve Medtech Partners directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Evolve Medtech Partners

What sectors does Evolve Medtech Partners invest in?

Evolve Medtech Partners invests in Healthcare, Medical Devices, Biotechnology, Cardiology, Clinical Research and Orthopedics, and is based in Solana Beach, United States. Evolve Medtech Partners is listed as a venture capital in the ConnectSafely investor database.

What stage does Evolve Medtech Partners invest at?

Evolve Medtech Partners backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.

Which regions does Evolve Medtech Partners invest in?

Evolve Medtech Partners invests across United States.

Who are the partners at Evolve Medtech Partners?

Team members listed for Evolve Medtech Partners include Christopher Hasselwander (Principal Engineer) and Steve Howard (Principal Engineer).

What companies has Evolve Medtech Partners invested in?

Evolve Medtech Partners's portfolio includes Breakthrough micro-catheter-based solution for treating chronic total occlusions (CTOs), Patented RF transseptal access system, Next-generation non-thermal cardiac ablation system, Pain-free, wireless, and battery-less medical device for the treatment of atrial fibrillation (Afib), Single-use surgical retractor technology, Endoscopic technology development structured as a build-to-buy with a strategic medical device company, Over-the-wire transseptal access technology used in electrophysiology and structural heart procedures and Vector Vascular.

How do I contact Evolve Medtech Partners?

Evolve Medtech Partners's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database